SCHEMBL5099274

SCHEMBL5099274

CCC(C(=O)O)c1ccc(O)c(N)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
GAA P10253 2/20 0.60
USP2 O75604 1/20 0.60
PKM P14618 1/20 0.60
HPGD P15428 1/20 0.60
ALOX15 P16050 1/20 0.60
HSD17B10 Q99714 1/20 0.60
ALOX12 P18054 1/20 0.53
HTT P42858 1/20 0.53
HIF1A Q16665 1/20 0.53
AKR1C3 P42330 13/20 0.51
AKR1C2 P52895 13/20 0.51
AKR1C1 Q04828 2/20 0.51
PTGS1 P23219 1/20 0.51
AKR1B10 O60218 1/20 0.41
AKR1C4 P17516 1/20 0.41
CHEK1 O14757 1/20 0.41
FYN P06241 1/20 0.41
PDGFRB P09619 1/20 0.41
PIM1 P11309 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27951170 0.87 ALDH1A1 (0.53) ALDH1A1GAAUSP2PKMHPGD
SCHEMBL12095399 0.87 ALDH1A1 (0.60) ALDH1A1GAAUSP2PKMHPGD
Hydrochloric Acid SCHEMBL12100554 0.85 GAA (0.58) ALDH1A1GAAUSP2PKMHPGD
SCHEMBL31368762 0.84 AKR1C3 (0.55) GAAALOX15HSD17B10HIF1AAKR1C3
SCHEMBL26170478 0.84 AKR1C3 (0.55) GAAALOX15HSD17B10HIF1AAKR1C3
SCHEMBL11193984 0.81 AKR1C3 (0.53) AKR1C3AKR1C2AKR1C1PTGS1AKR1B10
SCHEMBL272899 0.80 ALDH1A1 (0.70) ALDH1A1GAAUSP2PKMHPGD
SCHEMBL2795502 0.80 AKR1C3 (0.61) AKR1C3AKR1C2AKR1C1PTGS1AKR1B10
SCHEMBL1556908 0.80 AKR1C3 (0.51) AKR1C3AKR1C2AKR1C1PTGS1AKR1B10
SCHEMBL298386 0.79 TSHR (0.67) ALDH1A1GAAHTTAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348017-B2 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin SHISEIDO CO., LTD. (JP) 2008-03-25 US disclosed
US-20040236111-A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin SHISEIDO CO., LTD. (JP) 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040236111-A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin MMP1, MMP2, MMP3 ALDH1A1 253/4885GAA 785/4885USP2 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.